Walleye Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-40,000
Closed -$1.64M 3059
2024
Q2
$1.64M Hold
40,000
﹤0.01% 901
2024
Q1
$1.69M Buy
40,000
+12,950
+48% +$547K ﹤0.01% 833
2023
Q4
$1.15M Buy
+27,050
New +$1.15M ﹤0.01% 844
2023
Q2
Hold
0
3000
2023
Q1
Hold
0
2858
2022
Q4
Hold
0
2718